Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 456
Ph III recruiting: 55
Growth YoY: −3.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 101–150 of 962 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07737795	Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer	not yet recruiting	Phase 2	66	University of OklahomaOTHER	1	Jul 30, 2026	clinicaltrials
NCT04974944	First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer	terminated	Phase 2	35	Sun Yat-Sen University Cancer CenterOTHER	1	Jul 29, 2026	clinicaltrials